Brighton Jones’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-35,726
Closed -$27.9K – 1451
2026
Q2
$27.9K Buy
35,726
+13,239
+59% +$12.3K ﹤0.01% 1390
2026
Q1
$13.6K Buy
+22,487
New +$23.4K ﹤0.01% 1194

Other funds holding HUMA

Brighton Jones's HUMA Position: Q3 2026 in Review

Brighton Jones sold out of Humacyte (HUMA) in Q3 2026, closing a stake of 35,726 shares — an estimated $27.9K sold.

Brighton Jones first reported a position in HUMA in Q1 2026 and held it in 2 quarters. The position peaked at $27.9K in Q2 2026. 110 funds tracked by Wall St. Rank hold HUMA as of Q3 2026.

  • Brighton Jones reported no remaining Humacyte position as of Q3 2026 after selling out during the quarter.
  • Brighton Jones sold 35,726 Humacyte shares in Q3 2026, an estimated $27.9K.
  • Brighton Jones first reported a position in Humacyte in Q1 2026 and held it in 2 quarters.
  • Brighton Jones's Humacyte position peaked at $27.9K in Q2 2026.
  • 110 funds tracked by Wall St. Rank held Humacyte as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.